DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
57 hedge funds and large institutions have $22.8M invested in DMK Pharmaceuticals Corporation Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
45% less call options, than puts
Call options by funds: $311K | Put options by funds: $568K
Holders
57
Holding in Top 10
–
Calls
$311K
Puts
$568K
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.37M | |
| 3 | +$261K | |
| 4 |
Morgan Stanley
New York
|
+$225K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$211K |
Top Sellers
| 1 | -$254K | |
| 2 | -$164K | |
| 3 | -$141K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$137K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$100K |